How to Create a Vaccine Rollout Communication Deck

Vaccine rollout communication requires coordinating multiple audiences simultaneously: healthcare providers, public health workers, government officials, community organizations, and the general public. Each needs different information, at different levels of detail, delivered through different channels. A well-structured rollout communication deck serves as the backbone of that coordination.

The Two Types of Rollout Decks

Internal operational deck: Used by public health staff, healthcare systems, pharmacies, and government partners to coordinate logistics, prioritization, and reporting. Detailed, technical, regularly updated.

External public communication deck: Used in community meetings, press briefings, and digital channels to answer public questions, build confidence, and drive uptake. Clear, accessible, trust-focused.

Build both. This guide covers the structure of each.

---

Internal Operational Rollout Deck

Slide 1 — Current Rollout Status Dashboard

At any stage of rollout, leadership needs a snapshot: doses allocated, doses administered, percentage of target population vaccinated, doses in transit vs. on hand, and appointments scheduled vs. available.

A simple table or scorecard format updates this slide regularly. It becomes the opening slide of every coordination call.

Slide 2 — Prioritization Framework

Who is eligible now, who is next, and what criteria determine the sequence. For most vaccine rollouts, prioritization follows a tiered approach based on risk and exposure:

• Tier 1: Healthcare workers and first responders
• Tier 2: Residents and staff of congregate settings, adults 65+
• Tier 3: Adults with high-risk medical conditions
• Tier 4: Essential workers
• Tier 5: General population

Be explicit about eligibility criteria and how they will be verified. Ambiguity here generates calls, complaints, and inequitable administration.

Slide 3 — Allocation and Supply Chain

Doses allocated to each jurisdiction, distribution mechanism, cold chain requirements (temperature thresholds, storage duration, transport limitations), and the cadence of allocation updates from the federal or state level.

Highlight any product-specific differences if multiple vaccines are in the rollout (e.g., different storage temperatures, different dosing schedules, different age indications).

Slide 4 — Administration Sites and Capacity

Map or list of authorized administration sites: hospitals, health department clinics, pharmacies, federally qualified health centers, mass vaccination sites. For each site or site type: hours of operation, appointment mechanism, walk-in availability, and current capacity.

Identify gaps in access — geographic areas, communities, or populations that are underserved by the current site distribution.

Slide 5 — Appointment and Registration System

How do people find out about eligibility? How do they register? What happens if they don't have internet access? What is the no-show rate and the plan for standby lists?

Walk through the patient journey from notification to appointment to post-vaccination monitoring.

Slide 6 — Reporting and Data Flow

How are administered doses reported? Immunization information system (IIS) integration, reporting deadlines, data quality protocols, and the escalation path for reporting discrepancies.

Define how data will be disaggregated — by age, race/ethnicity, zip code — for equity monitoring.

Slide 7 — Equity and Access Plan

Which populations are at risk for lower uptake due to access barriers, vaccine hesitancy, or language/cultural factors? What targeted outreach, mobile vaccination, or community partnership strategies are in place?

Track vaccination coverage by demographic group and compare to population distribution. Disproportionately low coverage in high-risk communities is an early warning sign.

Slide 8 — Communications Plan

Who is communicating what to which audiences and when? Include: public-facing website updates, press briefings, social media cadence, partner communications, healthcare provider updates, and media protocol.

Slide 9 — Adverse Event Reporting and Safety Monitoring

What is the process for identifying, reporting, and following up on adverse events following immunization (AEFIs)? VAERS reporting requirements, state reporting protocols, and the communication plan if a safety signal emerges.

Slide 10 — Open Issues and Escalation Log

A regularly updated table of outstanding operational issues, who owns each, and the target resolution date. This transforms the coordination call from a status update into a problem-solving session.

---

External Public Communication Deck

Slide 1 — What's Available Now

Plain-language statement of which vaccines are available, who is currently eligible, and how to get vaccinated. Lead with what people can do, not with technical background.

Slide 2 — Why Get Vaccinated

Benefits of vaccination for the individual and the community. Include:

• Protection against serious illness, hospitalization, and death
• Reduced transmission to vulnerable family members
• Community immunity benefits
• Any reduced quarantine or testing requirements for vaccinated individuals

Use concrete language: "People who are vaccinated are X times less likely to be hospitalized."

Slide 3 — How the Vaccines Work

A brief, visual explanation of the mechanism — mRNA, viral vector, or protein subunit, depending on the specific vaccines in the rollout. No biology degree required. Focus on: "Your body learns to recognize the virus without being exposed to it" rather than molecular detail.

Address the most common concern: "Does it change my DNA?" No. Explain why briefly (mRNA never enters the nucleus, where DNA is stored).

Slide 4 — Safety and Clinical Trial Data

How the vaccine was tested, how many people participated in clinical trials, what the approval or authorization process involved, and what ongoing safety monitoring is in place. This is not a full clinical review — it's enough to address the "it was rushed" concern.

Slide 5 — Side Effects: What to Expect

Common side effects (arm soreness, fatigue, headache, mild fever) are a sign the immune system is responding. Duration (typically 1–2 days). What to do if side effects are more severe or last longer. When to call a doctor.

Slide 6 — Where and How to Get Vaccinated

Find a location, make an appointment, what to bring, what to expect at the appointment, what happens afterward (observation period, VAERS information, VIS).

Slide 7 — Questions and Answers

Address the most common questions directly:

• Can I choose which vaccine I get?
• Can I get vaccinated if I already had COVID/the flu/etc.?
• Do I still need to take precautions after vaccination?
• Is it safe if I'm pregnant or breastfeeding?
• What if I'm immunocompromised?

Prepare answers that are honest about what is and isn't known.

---

Presentation Notes

Both decks should be updated on a defined cadence — the operational deck at minimum weekly, the public deck whenever eligibility or availability changes significantly. Build them in slide-deck.io with a version date prominently displayed on every slide so audiences always know whether they're looking at current information.